Immunogenicity Assessment from Phase 3 Galcanezumab Trials in Patients with Episodic or Chronic Migraine Martinez, J. M., Hindiyeh, N., Anglin, G., Kalidas, K., Hodsdon, M. E., Kielbasa, W., Moser, B. A., Pearlman, E., Garces, S. LIPPINCOTT WILLIAMS & WILKINS. 2019

View details for Web of Science ID 000475965900416